Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells
- 7 January 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (2), 250-259
- https://doi.org/10.1016/j.vaccine.2008.10.055
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptorMolecular Immunology, 2008
- Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin’s lymphomas: a focus on FavId™Expert Opinion on Biological Therapy, 2005
- Mannoproteins fromCryptococcus neoformansPromote Dendritic Cell Maturation and ActivationInfection and Immunity, 2005
- Clinical Outcome of Lymphoma Patients After Idiotype Vaccination Is Correlated With Humoral Immune Response and Immunoglobulin G Fc Receptor GenotypeJournal of Clinical Oncology, 2004
- Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating FactorClinical Cancer Research, 2004
- Dual function of C-type lectin-like receptors in the immune systemCurrent Opinion in Cell Biology, 2003
- Virus-like particle and DNA-based candidate AIDS vaccinesVaccine, 2003
- The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cellsEuropean Journal of Immunology, 1997
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.The Journal of Experimental Medicine, 1995
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyThe New England Journal of Medicine, 1982